CX Daily: Behind China’s Struggle To Bring Down Drug-Resistant TB
Listen to the full version

Tuberculosis /
In Depth: Behind China’s struggle to bring down drug-resistant TB
Wang Li used to work as a highway surveyor in Southwest China’s Sichuan province. But after being diagnosed with multidrug-resistant tuberculosis (MDR-TB) in May 2023, the 25-year-old had to quit his job and stay at home. Wang told Caixin that his treatment regimen involves taking as many as 47 pills a day for up to 20 months.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Save an extra $50. Introductory offer for new readers. Subscribe now.
- MOST POPULAR



